stage IV colon cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Stage IV colon cancer is characterized by the invasion of cancer cells through the colon wall, allowing them to enter the bloodstream or lymphatic system. This dissemination facilitates metastasis, with common sites including the liver and lungs, significantly impacting organ function.

• Secondary mechanism: Angiogenesis plays a crucial role in stage IV colon cancer. Tumors secrete factors that promote new blood vessel formation, supplying the tumor with nutrients and oxygen, thereby supporting tumor growth and further metastatic spread.

• Key complication: Metastatic spread to vital organs can lead to organ dysfunction, resulting in systemic symptoms like jaundice in liver involvement or respiratory issues when the lungs are affected, which complicates treatment and worsens prognosis.

Patient Profile

Demographics:

62-year-old male, retired school teacher

History:

• Key past medical history: Diagnosed with stage IV colon cancer 18 months ago, type 2 diabetes, hypertension

• Current medications: Capecitabine, Bevacizumab, Metformin, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing abdominal pain and fatigue

• Key symptoms: Abdominal distension, unintentional weight loss, occasional nausea, altered bowel habits, shortness of breath

• Vital signs: Blood pressure 145/90 mmHg, heart rate 92 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 92% on room air

Section 1

The nursing team conducts an initial assessment of the patient, noting significant findings that indicate potential complications associated with his stage IV colon cancer. During the physical examination, the nurse observes notable abdominal distension, with signs of ascites, suggesting possible liver involvement. The patient's abdomen is tender upon palpation, especially in the right upper quadrant, raising concerns about hepatic metastasis. His altered bowel habits, coupled with occasional nausea, suggest gastrointestinal obstruction or motility issues. Additionally, his respiratory rate is elevated, and he exhibits mild dyspnea with a decreased oxygen saturation level of 92% on room air, indicating possible pulmonary involvement.

Laboratory tests reveal elevated liver enzymes, including AST and ALT, hinting at hepatic dysfunction. The complete blood count shows mild anemia, which may be contributing to his fatigue and increased heart rate. An elevated carcinoembryonic antigen (CEA) level, a tumor marker for colon cancer, suggests disease progression. Imaging studies, such as a CT scan of the abdomen and chest, are ordered and reveal multiple hepatic lesions and new nodules in the lungs, confirming metastasis to these vital organs.

These findings necessitate a multidisciplinary approach to manage the complications arising from metastasis. The healthcare team considers adjusting the patient's current treatment regimen to address the liver and lung involvement. Palliative care measures, such as managing ascites and addressing respiratory symptoms, are also prioritized to improve the patient's quality of life. The team discusses these changes with the patient and his family, ensuring they understand the implications and the focus on symptom management moving forward. This stage in the patient's journey requires careful monitoring and timely interventions to address the evolving complications and maintain his comfort and dignity.

Section 2

As the patient's condition progresses, the healthcare team notes a significant change in his status, highlighting the dynamic nature of his stage IV colon cancer. Over the past few days, the patient has developed worsening abdominal pain, which has become more persistent and severe, requiring increasing doses of analgesics for relief. His nausea has intensified, leading to a decreased oral intake and subsequent weight loss. Furthermore, the patient's dyspnea has become more pronounced, with oxygen saturation levels dropping to 88% on room air, necessitating supplemental oxygen therapy. These developments raise concerns about the potential for further gastrointestinal obstruction and exacerbation of pulmonary metastasis.

In response to these changes, the team conducts a set of follow-up diagnostic tests to better understand the underlying causes of his declining status. A repeat CT scan of the abdomen reveals a partial bowel obstruction, likely due to tumor progression, contributing to the patient's escalating abdominal discomfort and nausea. Additionally, the chest imaging shows an increase in the size and number of pulmonary nodules, indicating further metastatic spread and explaining the worsening respiratory symptoms. Laboratory results reveal a further increase in liver enzymes, with AST and ALT levels now significantly elevated, suggesting ongoing hepatic strain and possible liver failure.

Based on these findings, the healthcare team adjusts the patient's management plan, emphasizing both symptom control and palliative measures. Interventions such as paracentesis are considered to alleviate ascites-related discomfort, while antiemetics and appetite stimulants are prescribed to improve nutritional intake. To address the respiratory challenges, a transition to a higher flow of supplemental oxygen is initiated, along with potential discussions around more advanced interventions like non-invasive ventilation if needed. The team remains vigilant, closely monitoring the patient's response to these interventions while providing comprehensive support to the patient and his family, ensuring informed decision-making and alignment with the patient's goals of care.

Section 3

In the days following the adjustment of the management plan, the healthcare team continues to assess the patient's response to the interventions. On initial assessment, the patient's abdominal pain appears slightly more controlled, with a reduction in the need for high doses of analgesics. However, the pain is still present, suggesting that the partial bowel obstruction remains a significant issue. The nursing staff notes that his abdominal distension persists, and his bowel sounds are reduced, indicating ongoing gastrointestinal dysfunction. Despite the use of antiemetics, the patient’s nausea is only partially alleviated, and he continues to struggle with maintaining adequate nutritional intake.

Respiratory assessment reveals that while the transition to a higher flow of supplemental oxygen initially stabilized the patient's oxygen saturation levels at around 92%, any attempt to wean him back to room air results in a rapid desaturation to 85-86%. Auscultation of the lungs shows diminished breath sounds bilaterally with fine crackles at the bases, consistent with the progression of pulmonary metastases. The patient expresses increased fatigue and weakness, which may be attributable to both the decreased nutritional intake and the growing respiratory effort required to maintain adequate oxygenation.

Laboratory results show a further rise in liver enzymes, with AST at 190 U/L and ALT at 210 U/L, signaling a worsening hepatic function. Bilirubin levels have also risen to 3.5 mg/dL, contributing to the patient's jaundice and indicating potential obstructive pathology within the liver. This biochemical evidence, coupled with the clinical signs, prompts the team to consider the possibility of hepatic encephalopathy as a new complication, especially given the patient's episodes of confusion and altered mental status. The team is now tasked with balancing aggressive symptom management while facilitating discussions about the potential need for advanced directives and end-of-life care planning, aligning with the patient's values and goals.

Section 4

In the subsequent days, the patient's status continues to evolve, with new complications adding layers of complexity to his care. During routine monitoring, the nursing staff observes a subtle yet noticeable increase in the patient's confusion and disorientation, which, alongside the elevated bilirubin and liver enzymes, raises the suspicion of hepatic encephalopathy. The patient's family reports that he is more somnolent and has moments of agitation, which are atypical for him. The healthcare team decides to initiate lactulose therapy to help reduce ammonia levels, aiming to mitigate the neurological symptoms.

Concurrently, the patient's respiratory status becomes more precarious. His oxygen requirements escalate, necessitating the use of a non-rebreather mask to maintain saturation levels above 90%. Auscultation reveals an increase in crackles throughout both lung fields, and a chest X-ray confirms the presence of pleural effusions, likely secondary to his metastatic disease. The decision is made to perform a thoracentesis to alleviate respiratory distress and improve comfort. Despite the intervention, the patient's respiratory effort remains significant, and he continues to exhibit profound fatigue.

The team faces the challenge of managing these intertwined complications while respecting the patient’s values and his previously expressed wish to avoid invasive procedures. They engage in discussions with the patient and his family about the goals of care, emphasizing comfort and quality of life. The healthcare team explores the possibility of transitioning to a palliative care approach, focusing on symptom relief and supporting the family through this difficult phase of the patient’s journey. These conversations are pivotal, as they guide the future direction of care, ensuring it aligns with the patient's wishes while addressing his immediate medical needs.

Section 5

As the healthcare team continues to navigate the complexities of the patient's condition, a new complication arises: significant renal impairment. Recent laboratory results reveal that the patient's creatinine levels have doubled within 48 hours, rising from 1.2 mg/dL to 2.4 mg/dL, with a concurrent drop in urine output to less than 400 mL over the last 24 hours, indicating acute kidney injury (AKI). The patient's blood urea nitrogen (BUN) is also elevated at 45 mg/dL. These changes suggest a possible prerenal etiology due to decreased perfusion, likely exacerbated by the patient's ongoing hepatic dysfunction and fluid shifts from the pleural effusions.

The nursing staff closely monitors the patient's fluid status, assessing for signs of volume overload while balancing the risk of further compromising renal function. The patient’s blood pressure has dropped slightly, averaging 92/58 mmHg, which might contribute to the renal underperfusion. The decision is made to adjust his fluid management plan, cautiously administering isotonic fluids while keeping a vigilant eye for any signs of worsening pulmonary status. The medical team also considers the potential need for renal replacement therapy, though it is mindful of the patient's preference to avoid invasive interventions.

In light of these developments, the healthcare team re-evaluates the patient's medication regimen, particularly focusing on any nephrotoxic agents that could be contributing to the renal decline. The patient's diuretics are reassessed to prevent further dehydration, and his lactulose dosage is adjusted to maintain efficacy without inducing excessive diarrhea, which could further impact his hydration status. These steps, combined with ongoing discussions about the goals of care, underscore the importance of collaborative decision-making, ensuring that each intervention aligns with the patient's values while addressing these new challenges.